Hyperspectral imaging as a part of pharmaceutical product design

Research output: Chapter in Book/Report/Conference proceedingBook chapterResearchpeer-review

Standard

Hyperspectral imaging as a part of pharmaceutical product design. / Bøtker, Johan; Wu, Jian X.; Rantanen, Jukka.

Data Handling in Science and Technology. Elsevier, 2020. p. 567-581 (Data Handling in Science and Technology, Vol. 32).

Research output: Chapter in Book/Report/Conference proceedingBook chapterResearchpeer-review

Harvard

Bøtker, J, Wu, JX & Rantanen, J 2020, Hyperspectral imaging as a part of pharmaceutical product design. in Data Handling in Science and Technology. Elsevier, Data Handling in Science and Technology, vol. 32, pp. 567-581. https://doi.org/10.1016/B978-0-444-63977-6.00022-5

APA

Bøtker, J., Wu, J. X., & Rantanen, J. (2020). Hyperspectral imaging as a part of pharmaceutical product design. In Data Handling in Science and Technology (pp. 567-581). Elsevier. Data Handling in Science and Technology Vol. 32 https://doi.org/10.1016/B978-0-444-63977-6.00022-5

Vancouver

Bøtker J, Wu JX, Rantanen J. Hyperspectral imaging as a part of pharmaceutical product design. In Data Handling in Science and Technology. Elsevier. 2020. p. 567-581. (Data Handling in Science and Technology, Vol. 32). https://doi.org/10.1016/B978-0-444-63977-6.00022-5

Author

Bøtker, Johan ; Wu, Jian X. ; Rantanen, Jukka. / Hyperspectral imaging as a part of pharmaceutical product design. Data Handling in Science and Technology. Elsevier, 2020. pp. 567-581 (Data Handling in Science and Technology, Vol. 32).

Bibtex

@inbook{31c479e49a714a87a54098a057835dac,
title = "Hyperspectral imaging as a part of pharmaceutical product design",
abstract = "Imaging is getting an important element of the modern drug development process. Different hyperspectral imaging tools can provide in-depth understanding of complex pharmaceutical products including not only phenomena captured by the laboratory-based off-line instruments but also increasingly tools capable of fulfilling the process analytical measurement scenarios. Information related to spatial distribution of the components in pharmaceutical products can be explored using infrared, near-infrared, Raman, and ultraviolet mapping, as well as using RGB imaging. These tools are generally accepted by the regulatory bodies, and at the same time, they are becoming a natural part of drug development process. In the future, hyperspectral imaging will be a key enabling part of the continuously operating production systems.",
keywords = "Chemical imaging, Near-IR (NIR) imaging, Pharmaceutical, Raman imaging, Tablets",
author = "Johan B{\o}tker and Wu, {Jian X.} and Jukka Rantanen",
year = "2020",
doi = "10.1016/B978-0-444-63977-6.00022-5",
language = "English",
series = "Data Handling in Science and Technology",
publisher = "Elsevier",
pages = "567--581",
booktitle = "Data Handling in Science and Technology",
address = "Netherlands",

}

RIS

TY - CHAP

T1 - Hyperspectral imaging as a part of pharmaceutical product design

AU - Bøtker, Johan

AU - Wu, Jian X.

AU - Rantanen, Jukka

PY - 2020

Y1 - 2020

N2 - Imaging is getting an important element of the modern drug development process. Different hyperspectral imaging tools can provide in-depth understanding of complex pharmaceutical products including not only phenomena captured by the laboratory-based off-line instruments but also increasingly tools capable of fulfilling the process analytical measurement scenarios. Information related to spatial distribution of the components in pharmaceutical products can be explored using infrared, near-infrared, Raman, and ultraviolet mapping, as well as using RGB imaging. These tools are generally accepted by the regulatory bodies, and at the same time, they are becoming a natural part of drug development process. In the future, hyperspectral imaging will be a key enabling part of the continuously operating production systems.

AB - Imaging is getting an important element of the modern drug development process. Different hyperspectral imaging tools can provide in-depth understanding of complex pharmaceutical products including not only phenomena captured by the laboratory-based off-line instruments but also increasingly tools capable of fulfilling the process analytical measurement scenarios. Information related to spatial distribution of the components in pharmaceutical products can be explored using infrared, near-infrared, Raman, and ultraviolet mapping, as well as using RGB imaging. These tools are generally accepted by the regulatory bodies, and at the same time, they are becoming a natural part of drug development process. In the future, hyperspectral imaging will be a key enabling part of the continuously operating production systems.

KW - Chemical imaging

KW - Near-IR (NIR) imaging

KW - Pharmaceutical

KW - Raman imaging

KW - Tablets

U2 - 10.1016/B978-0-444-63977-6.00022-5

DO - 10.1016/B978-0-444-63977-6.00022-5

M3 - Book chapter

AN - SCOPUS:85072674681

T3 - Data Handling in Science and Technology

SP - 567

EP - 581

BT - Data Handling in Science and Technology

PB - Elsevier

ER -

ID: 245615615